Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| GABAergic neuron | 4 studies | 28% ± 12% | |
| astrocyte | 4 studies | 22% ± 5% | |
| glutamatergic neuron | 4 studies | 36% ± 15% | |
| epithelial cell | 3 studies | 20% ± 2% | |
| oligodendrocyte precursor cell | 3 studies | 25% ± 3% | |
| oligodendrocyte | 3 studies | 20% ± 2% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 5 studies | 27% ± 11% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| bladder | 100% | 272.24 | 21 / 21 | 100% | 7.27 | 504 / 504 |
| esophagus | 100% | 260.74 | 1445 / 1445 | 100% | 7.00 | 183 / 183 |
| ovary | 100% | 323.62 | 180 / 180 | 100% | 5.23 | 430 / 430 |
| breast | 100% | 293.30 | 459 / 459 | 100% | 6.89 | 1116 / 1118 |
| uterus | 100% | 329.18 | 170 / 170 | 100% | 6.98 | 458 / 459 |
| stomach | 100% | 224.22 | 358 / 359 | 100% | 7.08 | 286 / 286 |
| intestine | 100% | 295.04 | 966 / 966 | 100% | 6.90 | 525 / 527 |
| prostate | 100% | 307.64 | 245 / 245 | 99% | 5.30 | 499 / 502 |
| thymus | 100% | 349.81 | 653 / 653 | 99% | 5.35 | 600 / 605 |
| brain | 99% | 181.16 | 2619 / 2642 | 100% | 5.73 | 705 / 705 |
| lung | 99% | 237.92 | 572 / 578 | 100% | 6.84 | 1155 / 1155 |
| kidney | 100% | 308.92 | 89 / 89 | 99% | 5.53 | 891 / 901 |
| pancreas | 99% | 147.33 | 325 / 328 | 99% | 4.79 | 177 / 178 |
| liver | 100% | 208.46 | 226 / 226 | 97% | 3.68 | 393 / 406 |
| skin | 100% | 299.51 | 1808 / 1809 | 97% | 5.67 | 456 / 472 |
| adrenal gland | 100% | 314.11 | 258 / 258 | 97% | 3.52 | 222 / 230 |
| adipose | 100% | 270.80 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 8.05 | 29 / 29 |
| spleen | 100% | 394.85 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 6.67 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 2.81 | 1 / 1 |
| blood vessel | 100% | 220.36 | 1331 / 1335 | 0% | 0 | 0 / 0 |
| muscle | 100% | 203.07 | 799 / 803 | 0% | 0 | 0 / 0 |
| heart | 98% | 227.94 | 847 / 861 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 88% | 3.25 | 70 / 80 |
| peripheral blood | 71% | 176.38 | 656 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0006119 | Biological process | oxidative phosphorylation |
| GO_0006392 | Biological process | transcription elongation by mitochondrial RNA polymerase |
| GO_0006264 | Biological process | mitochondrial DNA replication |
| GO_0006390 | Biological process | mitochondrial transcription |
| GO_0005739 | Cellular component | mitochondrion |
| GO_1990904 | Cellular component | ribonucleoprotein complex |
| GO_0005759 | Cellular component | mitochondrial matrix |
| GO_0042645 | Cellular component | mitochondrial nucleoid |
| GO_0005515 | Molecular function | protein binding |
| GO_0008821 | Molecular function | crossover junction DNA endonuclease activity |
| GO_0003723 | Molecular function | RNA binding |
| GO_0030337 | Molecular function | DNA polymerase processivity factor activity |
| Gene name | TEFM |
| Protein name | Transcription elongation factor, mitochondrial |
| Synonyms | C17orf42 |
| Description | FUNCTION: Transcription elongation factor which increases mitochondrial RNA polymerase processivity . Regulates transcription of the mitochondrial genome, including genes important for the oxidative phosphorylation machinery . . |
| Accessions | ENST00000581216.6 [Q96QE5-1] Q96QE5 ENST00000306049.9 [Q96QE5-4] J3KTG7 ENST00000580840.1 |
